The Report Biopharmaceutical Third Party Logistics (3PL) Market Size, Share & Trends Analysis
Report By Supply Chain (Cold Chain, Non-cold Chain), By Service, By Region, And
Segment Forecasts, 2019 – 2025
The global Biopharmaceutical Third Party
Logistics (3PL) Market size is expected to reach USD 120.64 billion by
2025, at a CAGR 4.9% over the forecast period, according to a new report by
Grand View Research, Inc. The market for biopharmaceutical third party
logistics (3PL) is majorly driven by rising demand for temperature controlled
logistic services to transport biologics in various regions and growing
distribution networks of biopharmaceutical companies to improve their sales.
Rising adoption of automated storage and retrieval systems in the emerging
countries is an ongoing trend in the pharmaceutical logistics companies that
has gained a significant traction.
Furthermore,
the trend of shifting from small molecule drugs to biopharmaceuticals, mainly
vaccines and biologics, is projected to drive the market. Since, these small
molecule drugs are temperature sensitive products, demand for temperature
controlled transportation and storage increases and thus is responsible for the
market growth. As of now, the pharmaceutical sales through distributors have
grown from USD 304.6 billion in 2013 to USD 440.2 billion in 2016.
However, the
average number of manufacturers per distributor had declined from 1,474 in 2014
to 1,211 in 2016. This data depicts that there is an increase in quantity of
pharmaceutical products being distributed, and thus, is expected to surge the
demand for 3PL services.
Additionally,
environmental concerns and cost have caused a slight shift in the means of
transport used for commercial product, moving from airway to seaway shipping
and in roadways from truck to intermodal (both rail and truck). The intermodal
transport is majorly used by these pharmaceutical companies to reduce the
carbon footprint. The ongoing trend shows that the pharmaceutical manufacturers
have shifted towards sea freight to reduce the cost and risk factor. Although
for cold chain products, the companies still prefer air freight. However, some
of the large pharmaceutical companies are planning to transport 70% of their
products via ocean freight including cold chain products.
Access Research Report of Biopharmaceutical Third Party Logistics (3PL) Market @ www.grandviewresearch.com/industry-analysis/biopharmaceutical-third-party-logistics-3pl-market
Further key findings
from the report suggest:
· In 2018, non-cold chain logistics held the largest market
share in terms of revenue owing to the sales of a large number of drugs that do
not require any temperature control
· Cold chain logistics segment is expected to register the
faster CAGR over the forecast period owing to the demand for biologics, such as
cellular therapies, vaccines, and test kits
· Warehousing and storage held the largest market share
among the types of services in 2018
· Asia pacific expected to emerge with the fastest CAGR
over the forecast period owing to adoption of medicines from aging population
and shift of drug sales from brand manufacturers to generic
· Key players operating in the biopharmaceutical third
party logistics market include DHL International GmbH., SF Express, United Parcel
Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and
Nagel, Kerry logistics network limited and Agility
Grand View Research has segmented the global
biopharmaceutical third party logistics market on the basis of service,
participant, and region:
Biopharmaceutical Third
Party Logistics Supply Chain Outlook (Revenue, USD Million, 2014 - 2025)
·
Cold Chain
·
Non-cold Chain
Biopharmaceutical Third
Party Logistics Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Transportation
o Air Freight
o Sea
Freight
o Overland
·
Warehousing and Storage
·
Others
Biopharmaceutical Third
Party Logistics Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o U.K.
o Germany
o France
o Italy
o Spain
·
Asia Pacific
o China
o Japan
o India
o Australia
o New
Zealand
·
Latin America
o Brazil
o Mexico
o Argentina
·
Middle East & Africa
o South
Africa
o Saudi
Arabia
o UAE
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For
More Information: www.grandviewresearch.com
No comments:
Post a Comment